BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36654075)

  • 41. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
    Pei J; Wang Y; Li Y
    J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human endogenous retroviruses role in cancer cell stemness.
    Matteucci C; Balestrieri E; Argaw-Denboba A; Sinibaldi-Vallebona P
    Semin Cancer Biol; 2018 Dec; 53():17-30. PubMed ID: 30317035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
    Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
    Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ICAM3 mediates inflammatory signaling to promote cancer cell stemness.
    Shen W; Xie J; Zhao S; Du R; Luo X; He H; Jiang S; Hao N; Chen C; Guo C; Liu Y; Chen Y; Sun P; Yang S; Luo N; Xiang R; Luo Y
    Cancer Lett; 2018 May; 422():29-43. PubMed ID: 29477378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: A retrospective consecutive study.
    Pece S; Disalvatore D; Tosoni D; Vecchi M; Confalonieri S; Bertalot G; Viale G; Colleoni M; Veronesi P; Galimberti V; Di Fiore PP
    EBioMedicine; 2019 Apr; 42():352-362. PubMed ID: 30846393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling.
    Colacino JA; Azizi E; Brooks MD; Harouaka R; Fouladdel S; McDermott SP; Lee M; Hill D; Madden J; Boerner J; Cote ML; Sartor MA; Rozek LS; Wicha MS
    Stem Cell Reports; 2018 May; 10(5):1596-1609. PubMed ID: 29606612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
    Yang Z; Cui Y; Ni W; Kim S; Xuan Y
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
    Qin T; Li B; Feng X; Fan S; Liu L; Liu D; Mao J; Lu Y; Yang J; Yu X; Zhang Q; Zhang J; Song B; Li M; Li L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):287. PubMed ID: 30482232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.
    Samaeekia R; Adorno-Cruz V; Bockhorn J; Chang YF; Huang S; Prat A; Ha N; Kibria G; Huo D; Zheng H; Dalton R; Wang Y; Moskalenko GY; Liu H
    Clin Cancer Res; 2017 Feb; 23(4):1091-1103. PubMed ID: 27435395
    [No Abstract]   [Full Text] [Related]  

  • 51. Stem cell-like gene expression signature identified in ionizing radiation-treated cancer cells.
    Bae JH; Park SH; Yang JH; Yang K; Yi JM
    Gene; 2015 Nov; 572(2):285-91. PubMed ID: 26255092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of biomarkers for acute leukemia via machine learning-based stemness index.
    Zhang Y; Liu D; Li F; Zhao Z; Liu X; Gao D; Zhang Y; Li H
    Gene; 2021 Dec; 804():145903. PubMed ID: 34411647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES.
    Sokolov A; Paull EO; Stuart JM
    Pac Symp Biocomput; 2016; 21():405-16. PubMed ID: 26776204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
    Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
    Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. StemSC: a cross-dataset human stemness index for single-cell samples.
    Zheng H; Xie J; Song K; Yang J; Xiao H; Zhang J; Li K; Yuan R; Zhao Y; Gu Y; Zhao W
    Stem Cell Res Ther; 2022 Mar; 13(1):115. PubMed ID: 35313979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
    Boumahdi S; Driessens G; Lapouge G; Rorive S; Nassar D; Le Mercier M; Delatte B; Caauwe A; Lenglez S; Nkusi E; Brohée S; Salmon I; Dubois C; del Marmol V; Fuks F; Beck B; Blanpain C
    Nature; 2014 Jul; 511(7508):246-50. PubMed ID: 24909994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival.
    Grosse-Wilde A; Fouquier d'Hérouël A; McIntosh E; Ertaylan G; Skupin A; Kuestner RE; del Sol A; Walters KA; Huang S
    PLoS One; 2015; 10(5):e0126522. PubMed ID: 26020648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.